PRNewsWire
02 Apr 2026, 14:00 UTC · 30w ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Impact · against what's priced in
PepGen faces significant valuation pressure following a partial FDA clinical hold on its lead Phase 2 trial and a subsequent securities fraud investigation. Biogen and BP are also under investigation by the same law firm, though the materiality for these larger entities is significantly lower.
- PEPG−0.80
No priced-in read yet





